洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR1900027222】An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience

查看原文

立即下载

基本信息

登记号

ChiCTR1900027222

试验状态

尚未开始

药物名称

药物类型

规范名称

首次公示信息日的期

2019-11-05

临床申请受理号

靶点

适应症

抑郁症

试验通俗题目

An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience

试验专业题目

An East meets West theory of depression: from “Zang Fu” (臟腑) to neuroscience

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

350000

联系人通讯地址

请登录查看

临床试验信息

试验目的

To bridge the knowledge gap to understand TCM theories of depression using neurophysiological biomarkers

试验分类

请登录查看

试验类型

随机平行对照

试验分期

其它

随机化

we will recruit research associates to randomize the patients by computer software.

盲法

Open label

试验项目经费来源

香港理工大學康復科學系

试验范围

目标入组人数

实际入组人数

第一例入组时间

2020-10-16

试验终止时间

2021-10-16

是否属于一致性

入选标准

1. Aged 18-65 years; 2. Gender: females and males; 3. Western diagnosis: Diagnosed to be suffering from current episode of depression by a psychiatrist based on DSM-5 and subject to verification by Structured Clinical Interview for DSM-5 (SCID-5); 4. Baseline score of 12 or higher on the 17-item Hamilton Rating Scale for Depression (HAM-D17) (29); 5. Traditional Chinese medicine diagnosis: Diagnosed to be experienced the syndromes of liver Qi stagnation by International Medicine of Traditional Chinese Medicine; 6. The Montreal Cognitive Assessment (MoCA) of 20 or higher (30, 31); 7. Patients type: Day- and out-patient; 8. Voluntarily agree with the investigation and willing to sign a written informed consent form.；

排除标准

1. Primary diagnosis other than depression; 2. Pregnant or lactating women; 3. Have substance abuse or drug dependence; 4. Acute suicidal or violent behavior; 5. Regular practice of Baduanjin or any kinds of mind-body exercise in the past 6 months (29); 6. Are not able to participant in Baduanjin exercise due to mobility problem.；

研究者信息

研究负责人姓名

请登录查看

试验机构

香港理工大學康復科學系

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看